The Advanced Research Projects Agency for Health (ARPA‑H) designated up to $144 million to study anti‑aging approaches across multiple teams, signaling federal investment in translational aging research and biomarker development. The program will fund distributed projects aimed at identifying interventions and markers to prolong physiological resilience. Separately, the Barshop Institute at UT San Antonio secured up to $38 million from ARPA‑H to establish a national hub in aging and healthy‑longevity research. Barshop will coordinate multidisciplinary efforts spanning basic science, translational work, and clinical studies to accelerate geroscience interventions toward human testing. The funding package reflects growing public‑sector interest in aging biology as a therapeutic axis and a willingness to invest in de‑risking high‑impact, longer‑horizon programs. ARPA‑H emphasized project teams that combine engineering, clinical trial design and biomarkers to compress timelines.